An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional land...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/21/11481 |
_version_ | 1797512477774184448 |
---|---|
author | Heike Thiemeyer Leila Taher Jan Torben Schille Eva-Maria Packeiser Lisa K. Harder Marion Hewicker-Trautwein Bertram Brenig Ekkehard Schütz Julia Beck Ingo Nolte Hugo Murua Escobar |
author_facet | Heike Thiemeyer Leila Taher Jan Torben Schille Eva-Maria Packeiser Lisa K. Harder Marion Hewicker-Trautwein Bertram Brenig Ekkehard Schütz Julia Beck Ingo Nolte Hugo Murua Escobar |
author_sort | Heike Thiemeyer |
collection | DOAJ |
description | Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional landscape of canine PCa and the identification of diagnostic, prognostic and/or therapeutic biomarkers through a multi-step screening approach. RNA-Sequencing of ten malignant tissues and fine-needle aspirations (FNA), and 14 nonmalignant tissues and FNAs was performed to find differentially expressed genes (DEGs) and deregulated pathways. The 4098 observed DEGs were involved in 49 pathways. These 49 pathways could be grouped into five superpathways summarizing the hallmarks of canine PCa: (i) inflammatory response and cytokines; (ii) regulation of the immune system and cell death; (iii) cell surface and PI3K signaling; (iv) cell cycle; and (v) phagosome and autophagy. Among the highly deregulated, moderately to strongly expressed DEGs that were members of one or more superpathways, 169 DEGs were listed in relevant databases and/or the literature and included members of the PCa pathway, oncogenes, prostate-specific genes, and druggable genes. These genes are novel and promising candidate diagnostic, prognostic and/or therapeutic canine PCa biomarkers. |
first_indexed | 2024-03-10T06:01:22Z |
format | Article |
id | doaj.art-1d53b455aeab4aa2a873fbb0640d6ac9 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T06:01:22Z |
publishDate | 2021-10-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-1d53b455aeab4aa2a873fbb0640d6ac92023-11-22T20:53:18ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122211148110.3390/ijms222111481An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate GenesHeike Thiemeyer0Leila Taher1Jan Torben Schille2Eva-Maria Packeiser3Lisa K. Harder4Marion Hewicker-Trautwein5Bertram Brenig6Ekkehard Schütz7Julia Beck8Ingo Nolte9Hugo Murua Escobar10Small Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanyInstitute of Biomedical Informatics, Graz University of Technology, 8010 Graz, AustriaSmall Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanySmall Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanySmall Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanyInstitute of Pathology, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanyInstitute of Veterinary Medicine, University of Göttingen, 37077 Göttingen, GermanyChronix Biomedical GmbH, 37079 Göttingen, GermanyChronix Biomedical GmbH, 37079 Göttingen, GermanySmall Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanySmall Animal Clinic, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, GermanyProstate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional landscape of canine PCa and the identification of diagnostic, prognostic and/or therapeutic biomarkers through a multi-step screening approach. RNA-Sequencing of ten malignant tissues and fine-needle aspirations (FNA), and 14 nonmalignant tissues and FNAs was performed to find differentially expressed genes (DEGs) and deregulated pathways. The 4098 observed DEGs were involved in 49 pathways. These 49 pathways could be grouped into five superpathways summarizing the hallmarks of canine PCa: (i) inflammatory response and cytokines; (ii) regulation of the immune system and cell death; (iii) cell surface and PI3K signaling; (iv) cell cycle; and (v) phagosome and autophagy. Among the highly deregulated, moderately to strongly expressed DEGs that were members of one or more superpathways, 169 DEGs were listed in relevant databases and/or the literature and included members of the PCa pathway, oncogenes, prostate-specific genes, and druggable genes. These genes are novel and promising candidate diagnostic, prognostic and/or therapeutic canine PCa biomarkers.https://www.mdpi.com/1422-0067/22/21/11481canine prostate cancerRNA-Sequencingwhole transcriptome analysiscandidate biomarker genesanimal modelmolecular diagnostics |
spellingShingle | Heike Thiemeyer Leila Taher Jan Torben Schille Eva-Maria Packeiser Lisa K. Harder Marion Hewicker-Trautwein Bertram Brenig Ekkehard Schütz Julia Beck Ingo Nolte Hugo Murua Escobar An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes International Journal of Molecular Sciences canine prostate cancer RNA-Sequencing whole transcriptome analysis candidate biomarker genes animal model molecular diagnostics |
title | An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes |
title_full | An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes |
title_fullStr | An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes |
title_full_unstemmed | An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes |
title_short | An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes |
title_sort | rna seq based framework for characterizing canine prostate cancer and prioritizing clinically relevant biomarker candidate genes |
topic | canine prostate cancer RNA-Sequencing whole transcriptome analysis candidate biomarker genes animal model molecular diagnostics |
url | https://www.mdpi.com/1422-0067/22/21/11481 |
work_keys_str_mv | AT heikethiemeyer anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT leilataher anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT jantorbenschille anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT evamariapackeiser anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT lisakharder anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT marionhewickertrautwein anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT bertrambrenig anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT ekkehardschutz anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT juliabeck anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT ingonolte anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT hugomuruaescobar anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT heikethiemeyer rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT leilataher rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT jantorbenschille rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT evamariapackeiser rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT lisakharder rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT marionhewickertrautwein rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT bertrambrenig rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT ekkehardschutz rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT juliabeck rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT ingonolte rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes AT hugomuruaescobar rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes |